Literature DB >> 22262445

Measuring the inflammasome.

Olaf Gross1.   

Abstract

Inflammasomes are multiprotein complexes whose activity has been implicated in physiological and pathological inflammation. The hallmarks of inflammasome activation are the secretion of the mature forms of Caspase-1 and IL-1β from cells of the innate immune system. This protocol covers the methods required to study inflammasome activation using mouse bone marrow-derived dendritic cells (BMDCs) as a model system. The protocol includes the generation and handling of BMDCs, the stimulation of BMDCs with established Nlrp3 inflammasome activators, and the measurement of activation by both ELISA and western blot. These methods can be useful for the study of potential inflammasome activators, and of the signaling pathways involved in inflammasome activation. General considerations are provided that may help in the design and optimization of modified methods for the study of other types of inflammasomes and in other cell types.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22262445     DOI: 10.1007/978-1-61779-527-5_15

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  32 in total

1.  In vivo imaging of inflammasome activation reveals a subcapsular macrophage burst response that mobilizes innate and adaptive immunity.

Authors:  Pervinder Sagoo; Zacarias Garcia; Beatrice Breart; Fabrice Lemaître; David Michonneau; Matthew L Albert; Yves Levy; Philippe Bousso
Journal:  Nat Med       Date:  2015-12-21       Impact factor: 53.440

2.  Localization and functionality of the inflammasome in neutrophils.

Authors:  Martina Bakele; Melanie Joos; Sofia Burdi; Nicolas Allgaier; Simone Pöschel; Birgit Fehrenbacher; Martin Schaller; Veronica Marcos; Jasmin Kümmerle-Deschner; Nikolaus Rieber; Niels Borregaard; Amir Yazdi; Andreas Hector; Dominik Hartl
Journal:  J Biol Chem       Date:  2014-01-07       Impact factor: 5.157

3.  IL-1 in Colon Inflammation, Colon Carcinogenesis and Invasiveness of Colon Cancer.

Authors:  Elena Voronov; Ron N Apte
Journal:  Cancer Microenviron       Date:  2015-12-19

4.  Visualizing toll-like receptor-dependent phagosomal dynamics in murine dendritic cells using live cell microscopy.

Authors:  Adriana R Mantegazza; Michael S Marks
Journal:  Methods Mol Biol       Date:  2015

5.  Rapid inflammasome activation in microglia contributes to brain disease in HIV/AIDS.

Authors:  John G Walsh; Stacey N Reinke; Manmeet K Mamik; Brienne A McKenzie; Ferdinand Maingat; William G Branton; David I Broadhurst; Christopher Power
Journal:  Retrovirology       Date:  2014-05-13       Impact factor: 4.602

6.  A comprehensive guide to studying inflammasome activation and cell death.

Authors:  Rebecca E Tweedell; R K Subbarao Malireddi; Thirumala-Devi Kanneganti
Journal:  Nat Protoc       Date:  2020-09-07       Impact factor: 13.491

Review 7.  NLRP9 in innate immunity and inflammation.

Authors:  Breanne Mullins; Jueqi Chen
Journal:  Immunology       Date:  2020-12-20       Impact factor: 7.397

8.  No evidence that soluble TACI induces signalling via membrane-expressed BAFF and APRIL in myeloid cells.

Authors:  Josquin Nys; Cristian R Smulski; Aubry Tardivel; Laure Willen; Christine Kowalczyk; Olivier Donzé; Bertrand Huard; Henry Hess; Pascal Schneider
Journal:  PLoS One       Date:  2013-04-19       Impact factor: 3.240

9.  SESN2/sestrin2 suppresses sepsis by inducing mitophagy and inhibiting NLRP3 activation in macrophages.

Authors:  Min-Ji Kim; Soo Han Bae; Jae-Chan Ryu; Younghee Kwon; Ji-Hwan Oh; Jeongho Kwon; Jong-Seok Moon; Kyubo Kim; Atsushi Miyawaki; Min Goo Lee; Jaekyoon Shin; Young Sam Kim; Chang-Hoon Kim; Stefan W Ryter; Augustine M K Choi; Sue Goo Rhee; Ji-Hwan Ryu; Joo-Heon Yoon
Journal:  Autophagy       Date:  2016-06-23       Impact factor: 16.016

10.  ML365 inhibits TWIK2 channel to block ATP-induced NLRP3 inflammasome.

Authors:  Xiao-Yan Wu; Jin-Yan Lv; Shi-Qing Zhang; Xin Yi; Zi-Wei Xu; Yuan-Xing Zhi; Bo-Xin Zhao; Jian-Xin Pang; Ken Kin Lam Yung; Shu-Wen Liu; Ping-Zheng Zhou
Journal:  Acta Pharmacol Sin       Date:  2021-08-02       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.